Covered recipient · General Payments record
BALJIT S DHESI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$1,705.70
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,039.03 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $416.24 | 6 |
| Abbott Laboratories | $176.56 | 3 |
| CHIESI USA, INC. | $135.41 | 2 |
| Penumbra, Inc. | $123.55 | 1 |
| ShockWave Medical, Inc | $93.19 | 2 |
| Edwards Lifesciences Corporation | $67.77 | 1 |
| Medtronic, Inc. | $14.13 | 1 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $12.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.30 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125237020 | CMS |
| Abbott Laboratories | $143.76 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125237024 | CMS |
| Abbott Laboratories | $11.50 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125237022 | CMS |
| ABIOMED | $48.27 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142265034 | CMS |
| ABIOMED | $25.36 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142265036 | CMS |
| ABIOMED | $132.61 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142265032 | CMS |
| ABIOMED | $43.24 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142265044 | CMS |
| ABIOMED | $123.51 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142265078 | CMS |
| ABIOMED | $43.25 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142265076 | CMS |
| Chiesi USA, Inc. | $18.77 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151804815 | CMS |
| Chiesi USA, Inc. | $116.64 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151804820 | CMS |
| Edwards Lifesciences Corporation | $67.77 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138839212 | CMS |
| Medtronic, Inc. | $14.13 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119465283 | CMS |
| Penumbra, Inc. | $123.55 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095788965 | CMS |
| ShockWave Medical, Inc | $22.72 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152974768 | CMS |
| ShockWave Medical, Inc | $70.47 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152991535 | CMS |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $12.18 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080571079 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.